Primary Record
Golvatinib
- In stock
- 2,244 g
- Purity
- 98.3 %
- CAS
- 928037-13-2
Compound Identifiers & Properties
- CAS
- 928037-13-2
- PubChem CID
- 16118392
- SMILES
- CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
- Canonical SMILES
- CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1
Names & Synonyms
- Golvatinib
- Golvatinib (E7050)
- 928037-13-2
- golvatinibum
- Golvatinib (USAN)
- Golvatinib [USAN]
- Golvatinib tartrate
- E-7050
- E7050
- E7050;Golvatinib
- GolvatinibE7050)
- Golvatinib [USAN:INN]
- ;lvatinib(E7050)
- UNII-516Z3YP58E
- GOLVATINIB [INN]
- RefChem:144121
- Golvatinib (E7050)?
- D09ETH
- E7050 cpd
- 516Z3YP58E
- GOLVATINIB [WHO-DD]
- MFCD22124462
- cc-653
- C33H37F2N7O4
- DTXSID40239155
- GTPL7956
- orb1300700
- SCHEMBL1727298
- CHEMBL3039525
- SCHEMBL30498607
- SCHEMBL30498608
- DTXCID60161646
- EX-A830
- QCR-198
- CHEBI:177746
- UQRCJCNVNUFYDX-UHFFFAOYSA-N
- GLXC-90272
- HMS3651J19
- AOB87101
- BCP06122
- KS-00001D2X
- QCC30819
- BDBM50100615
- NSC800107
- NSC808608
- s2859
- ZINC43195317
- AKOS025404927
- CCG-270294
- CS-0595
- DB11977
- NSC-800107
- NSC-808608
- RL05842
- SB16585
- SDCCGSBI-0654486.P001
- NCGC00386210-06
- AC-30125
- AK174926
- AS-56994
- BC600351
- c-Met/VEGFR-2 Kinase Inhibitor E7050
- CID:16118392
- DA-73835
- HY-13068
- E 7050
- P2Y14 Antagonist Prodrug 7j hydrochloride
- SID:160644595
- 1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- AB0095633
- B1439
- FT-0700410
- NS00072534
- SW219690-1
- Y0446
- J2.800.704C
- A11396
- D10224
- E 7050;E7050
- W-5864
- A857765
- C548173
- BRD-K69001009-001-02-8
- Q27077829
- N-(2-Fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- B2693-460626
- C-Met and VEGF-2 tyrosine kinase inhibitor (oral, cancer), Eisai
- 1,1-CYCLOPROPANEDICARBOXAMIDE, N-(2-FLUORO-4-((2-(((4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)CARBONYL)AMINO)-4-PYRIDINYL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)-
- N-(2-fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1,1-Cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1- piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-N'-(4-fluorophenyl)-
- 1,1-Cyclopropanedicarboxamide, N-[2-fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-
- 1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1-N'-[2-luoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-luorophenyl)cyclopropane-1,1-dicarboxamide
- 1-N\'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1007601-96-8
- 1196681-49-8
- 2108968-42-7
- GV0
- N'-(2-fluoro-4-(2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxyphenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N'1-(2-fluoro-4-((2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N'1-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(2-Fluoro-4-((2-(((4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonyl)amino)pyridin-4- yl)oxy)phenyl)-N'-(4- fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(2-Fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[2-Fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; E-7050; E7050
- N-[2-Fluoro-4-[[2-[4-(4-methylpiperazino)piperidine-1-ylcarbonylamino]-4-pyridyl]oxy]phenyl]-N -(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[2-Fluoro-4-[2-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonylamino]-4-pyridyloxy]phenyl]-N -(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N~1~-[2-Fluoro-4-({2-[4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido]pyridin-4-yl}oxy)phenyl]-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N~1~-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N1'-[2-fluoro-4-[[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]-4-pyridyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide